Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | synuclein, alpha (non A4 component of amyloid precursor) | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | CMGC family protein kinase | 1.8345 | 1 | 1 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 1.0184 | 0.469 | 0.469 |
Onchocerca volvulus | Casein kinase II subunit beta homolog | 1.0184 | 0.469 | 0.5 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 1.0184 | 0.469 | 0.469 |
Loa Loa (eye worm) | CMGC/CK2 protein kinase | 1.8345 | 1 | 1 |
Echinococcus granulosus | casein kinase ii subunit alpha | 1.8345 | 1 | 1 |
Brugia malayi | Csnk2b protein | 1.0184 | 0.469 | 0.469 |
Schistosoma mansoni | protein kinase | 1.8345 | 1 | 1 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 1.0184 | 0.469 | 0.469 |
Toxoplasma gondii | CMGC kinase, CK2 family | 1.8345 | 1 | 1 |
Trypanosoma cruzi | casein kinase II, putative | 1.8345 | 1 | 1 |
Entamoeba histolytica | casein kinase II regulatory subunit family protein | 1.0184 | 0.469 | 0.469 |
Plasmodium vivax | unspecified product | 1.8345 | 1 | 1 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 1.0184 | 0.469 | 0.469 |
Trichomonas vaginalis | CMGC family protein kinase | 1.8345 | 1 | 1 |
Giardia lamblia | Casein kinase II beta chain | 1.0184 | 0.469 | 0.469 |
Giardia lamblia | Kinase, CMGC CK2 | 1.8345 | 1 | 1 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 1.0184 | 0.469 | 0.469 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 1.0184 | 0.469 | 0.469 |
Loa Loa (eye worm) | Csnk2b protein | 1.0184 | 0.469 | 0.469 |
Entamoeba histolytica | casein kinase, putative | 1.8345 | 1 | 1 |
Leishmania major | casein kinase II, putative | 1.8345 | 1 | 1 |
Entamoeba histolytica | protein kinase domain containing protein | 1.8345 | 1 | 1 |
Echinococcus multilocularis | casein kinase ii subunit alpha | 1.8345 | 1 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 1.8345 | 1 | 1 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 1.0184 | 0.469 | 0.469 |
Entamoeba histolytica | casein kinase II regulatory subunit family protein | 1.0184 | 0.469 | 0.469 |
Entamoeba histolytica | casein kinase II regulatory subunit family protein | 1.0184 | 0.469 | 0.469 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 1.0184 | 0.469 | 0.469 |
Onchocerca volvulus | Casein kinase II subunit beta homolog | 1.0184 | 0.469 | 0.5 |
Trichomonas vaginalis | CMGC family protein kinase | 1.8345 | 1 | 1 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 1.0184 | 0.469 | 0.469 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 1.0184 | 0.469 | 0.469 |
Trichomonas vaginalis | CMGC family protein kinase | 1.8345 | 1 | 1 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 1.0184 | 0.469 | 0.469 |
Plasmodium vivax | casein kinase 2, alpha subunit, putative | 1.8345 | 1 | 1 |
Trypanosoma brucei | Casein kinase II | 1.8345 | 1 | 1 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 1.0184 | 0.469 | 0.469 |
Trichomonas vaginalis | CMGC family protein kinase | 1.8345 | 1 | 1 |
Plasmodium falciparum | casein kinase 2, alpha subunit | 1.8345 | 1 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 1.8345 | 1 | 1 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 1.0184 | 0.469 | 0.469 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 1.0184 | 0.469 | 0.469 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 1.0184 | 0.469 | 0.469 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 3.1623 uM | PubChem BioAssay. qHTS of alpha-syn Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.